Skip to main content
. 2023 Nov 3;14:1242250. doi: 10.3389/fendo.2023.1242250

Table 6.

Comparison of data between single-focal tumor group and multi-focal tumor group in PTC patients.

Subject Unilateral tumor Bilateral tumors t/Z p
Number (%) 102 (37.78) 168 (62.22) - -
Age (years) 43.00 (33.75 - 52.00) 45.00 (36.00 - 53.00) -1.120 0.263
SSL (μg/L) 85.05 (74.88 - 92.15) 76.90 (69.43 - 85.25) -4.120 <0.001
BMI (kg/m2) 25.43 ± 4.10 26.44 ± 3.89 -2.017 0.045
Height (cm) 163.00 (159.75 - 170.00) 164.00 (160.00 - 170.00) -0.256 0.798
Weight (kg) 66.00 (57.38 - 79.63) 70.00 (62.00 - 80.00) -1.940 0.052
Waist (cm) 90.19 ± 11.41 91.43 ± 10.58 -0.906 0.366
SBP (mmHg) 122.16 ± 15.85 126.64 ± 17.43 -2.120 0.035
DBP (mmHg) 77.00 (69.00 - 84.25) 80.50 (75.00 - 91.75) -3.985 <0.001
FT3 (pmol/L) 4.96 (4.63 - 5.19) 4.94 (4.61 - 5.46) -1.368 0.171
FT4 (pmol/L) 17.43 (15.96 - 19.19) 17.80 (16.50 - 19.90) -0.681 0.496
TSH (uIU/mL) 2.28 (1.45 - 2.81) 1.54 (1.10 - 2.64) -1.007 0.314
TPOAB (IU/mL) 14.44 (10.30 - 19.37) 12.55 (9.99 - 20.57) -0.673 0.501
TGAB (IU/mL) 19.62 (15.81 - 56.31) 20.76 (15.42 - 48.62) -0.256 0.798

SSL, serum selenium level; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure yronine; FT4, free thyroxine; TSH, thyroid stimulating hormone; TPOAB, thyroidperoxidase antibodies; TGAB, thyroglobulin antibody.